文献速递产科母胎医学

低分子肝素促进滋养细胞分化与存活需依赖肝素结合性EGF样生长因子

Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor.
PubMed 文献 · Hum Reprod · 2017-01-01

本研究在体外用治疗剂量依诺肝素(10 IU/ml)处理早孕期胎盘外植体和HTR-8/SVneo细胞,发现低分子肝素增加HBEGF表达与分泌,并通过HBEGF信号促进滋养细胞绒毛外分化、体外侵袭并减少氧化应激下的凋亡;作者指出该研究仅限体外实验。

要点

  • 低分子肝素(依诺肝素10 IU/ml)增加滋养细胞HBEGF表达与分泌。
  • 低分子肝素促绒毛外分化和侵袭、减少氧化应激凋亡的作用依赖HBEGF信号。
  • 研究仅为体外实验,择期终止妊娠患者的 demographics 资料不可获得。

核心结论

  • 低分子肝素通过HBEGF信号刺激滋养细胞绒毛外分化、增加体外侵袭并减少氧化应激下的滋养细胞凋亡。

研究设计与样本

  • 体外研究:采用早孕期胎盘外植体(n=5)及由早孕期绒毛外植体建立的HTR-8/SVneo细胞系,在正常生理和病理条件下用低分子肝素处理。
  • 使用HBEGF高特异性拮抗剂CRM197及其他HBEGF下游信号抑制剂,确定低分子肝素与HBEGF的关系。

主要发现

  • 低分子肝素诱导绒毛外分化,依据滋养细胞侵袭实验和整合素(α6β4-α1β1)转换判定。
  • 在复氧损伤中,低分子肝素使细胞滋养细胞和HTR-8/SVneo细胞免于凋亡,依据TUNEL、caspase 3剪切和BCL-2α表达判定。
  • 使用CRM197、ERBB1和ERBB4阻断抗体、pan-ERBB抑制剂及去除细胞表面肝素证实,低分子肝素对滋养细胞侵袭和存活的作用依赖HBEGF信号。

关键数值与推荐

  • 低分子肝素使用治疗剂量依诺肝素10 IU/ml。
  • 绒毛外分化以整合素α6β4和α1β1相对水平评估。
  • 凋亡以TUNEL实验、caspase 3剪切和BCL-2α表达评估。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 本研究的主要局限性是仅进行了体外实验。
  • 择期终止妊娠患者的demographics资料不可获得。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does low molecular weight heparin (LMWH) require heparin-binding epidermal growth factor (EGF)-like growth factor (HBEGF) signaling to induce extravillous trophoblast differentiation and decrease apoptosis during oxidative stress? SUMMARY ANSWER: LMWH increased HBEGF expression and secretion, and HBEGF signaling was required to stimulate trophoblast extravillous differentiation, increase invasion in vitro and reduce trophoblast apoptosis during oxidative stress. WHAT IS KNOWN ALREADY: Abnormal trophoblast differentiation and survival contribute to placental insufficiency syndromes, including preeclampsia and intrauterine growth restriction. Preeclampsia often manifests as a pro-thrombotic state, with unsuccessful transformation of the spiral arteries that reduces oxygen supply and can produce placental infarction. LMWH improves placental function by increasing blood flow. Recent data suggest that the actions of LMWH transcend its anti-coagulative properties, but the molecular mechanism is unknown. There is evidence that LMWH alters the expression of human HBEGF in trophoblast cells, which regulates human trophoblast pathophysiology. HBEGF, itself, is capable of increasing trophoblast survival and invasiveness. STUDY DESIGN, SIZE, DURATION: First-trimester placental explants and the HTR-8/SVneo cell line, established using extravillous trophoblast outgrowths from first-trimester villous explants, were treated in vitro with LMWH to examine the effects on HBEGF signaling and trophoblast function under normal physiological and pathological conditions. A highly specific antagonist of HBEGF and other inhibitors of HBEGF downstream signaling were used to determine the relationship between LMWH treatment and HBEGF. PARTICIPANTS/MATERIALS, SETTING, METHODS: Placental tissues (n = 5) were obtained with IRB approval and patient consent from first-trimester terminations. Placental explants and HTR-8/SVneo cells were cultured on plastic or Matrigel™ and treated with a therapeutic dose of LMWH (Enoxaparin; 10 IU/ml), with or without CRM197, pan Erb-B2 Receptor Tyrosine Kinase (ERBB) inhibitor, anti-ERBB1 or ERBB4 blocking antibodies, or pretreatment of cells with heparitinase I. Extravillous differentiation was assessed by immunocytochemistry to determine the relative levels of integrins α6β4 and α1β1. Trophoblast invasiveness was assessed in villous explants by measuring outgrowth from villous tips cultured on Matrigel, and by invasion assays with HTR-8/SVneo cells cultured on Matrigel-coated transwell insert. Placental explants and HTR-8/SVneo cells were exposed to oxidative stress in a hypoxia-reoxygenation (H-R) model, measuring cell death by TUNEL assay, caspase 3 cleavage, and BCL-2α expression. MAIN RESULTS AND THE ROLE OF CHANCE: LMWH induced extravillous differentiation, according to trophoblast invasion assays and integrin (α6β4-α1β1) switching. Treatment with LMWH rescued cytotrophoblasts and HTR-8/SVneo cells from apoptosis during exposure to reoxygenation injury, based on TUNEL, caspase 3 cleavage and BCL-2α expression. Experiments using CRM197, ERBB1 and ERBB4 blocking antibodies, pan-ERBB inhibitor and removal of cell surface heparin demonstrated that the effects of LMWH on trophoblast invasion and survival were dependent upon HBEGF signaling. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The primary limitation of this study was the use of only in vitro experiments. Patient demographics from elective terminations were not available. WIDER IMPLICATIONS OF THE FINDINGS: These data provide new insights into the non-coagulation-related aspects of perinatal LMWH treatment in the management of placental insufficiency disorders. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by grants from the National Institutes of Health (HD071408 and HL128628), the March of Dimes, and the W. K. Kellogg Foundation. There were no conflicts or competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Bolnick AD, Bolnick JM, Kohan-Ghadr HR, et al. Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor. Hum Reprod. 2017. PMID: 28402449. doi:10.1093/humrep/dex069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。